alpha1-Adrenoceptor: A Promising Drug Target for Anxiety and Aggression Disorders

Target Name: alpha1-Adrenoceptor

NCBI ID: P5785

alpha1-Adrenoceptor

Other Name(s): alpha1-Adrenoceptor | alpha1-Adrenergic receptor

alpha1-Adrenoceptor: A Promising Drug Target for Anxiety and Aggression Disorders

The Alpha1-Adrenoceptor (伪1-Adrenoceptor), also known as Nonspecified Subtype, is a G protein-coupled receptor located in the vertebrate nervous system. It is a key regulator of behavioral processes such as anxiety, aggression, and sexual function. Despite its importance, little is known about the 伪1-Adrenoceptor, making it a promising drug target.

The 伪1-Adrenoceptor is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a key role in cellular signaling. GPCRs are composed of a transmembrane protein that interacts with a G protein, which in turn acts on a second transmembrane protein called a G-coupled receptor (GR). The 伪1-Adrenoceptor is a type of GPCR, and it is characterized by its transmembrane nature and its ability to interact with the GR尾2 subunit.

The 伪1-Adrenoceptor is involved in a wide range of physiological processes in the nervous system, including the regulation of anxiety and aggression. Studies have shown that 伪1-Adrenoceptor function is disrupted in various psychiatric and neurological disorders, including anxiety, depression, and schizophrenia . Additionally, altered 伪1-Adrenoceptor function has been implicated in several neurological diseases, including Alzheimer's disease and Parkinson's disease.

Given its involvement in so many important physiological processes, the 伪1-Adrenoceptor is a prime candidate for drug targeting. Activation of the 伪1-Adrenoceptor has been shown to produce a range of effects, including increased anxiety-like behavior, increased motor activity, and increased heart rate. Additionally, blockade of the 伪1-Adrenoceptor has been shown to be effective in treating anxiety and aggression disorders.

One potential drug that may target the 伪1-Adrenoceptor is a peptide called ANK-308. ANK-308 is a small peptide that consists of two domains: a N-terminal alpha-helix and a C-terminal T-loop. The N- The terminal domain contains a putative 伪1-Adrenoceptor binding site, while the C-terminal domain contains a potential binding site for a neurotransmitter.

Antk-308 has been shown to be a potent antagonist of the 伪1-Adrenoceptor, with a binding constant of 5 nM for the 伪1-Adrenoceptor and a binding constant of 20 pM for the GR尾2 subunit. This suggests that ANK-308 could be a Useful drug for the treatment of anxiety and aggression disorders.

Another potential drug that may target the 伪1-Adrenoceptor is a small molecule called NK-542. NK-542 is a purine nucleoside that is a potent inhibitor of the 伪1-Adrenoceptor. Studies have shown that NK-542 has a binding constant of 1 nM for the 伪1-Adrenoceptor and inhibits the 伪1-Adrenoceptor-GR尾2 interaction with a competitive effect.

While NK-542 is a promising drug candidate, its binding constant is relatively high for the 伪1-Adrenoceptor, which may limit its efficacy in treating anxiety and aggression disorders. Additionally, NK-542 is a broad inhibitor of GPCRs, which may have unintended consequences for the regulation of other physiological processes.

In conclusion, the 伪1-Adrenoceptor is a GPCR that is involved in a wide range of physiological processes in the nervous system. Its function is disrupted in various psychiatric and neurological disorders, making it a promising drug target. The potential drug ANK-308 has been shown to be a potent antagonist of the 伪1-Adrenoceptor, while NK-542 is a smaller molecule that is also shown to be an inhibitor of the 伪1-Adrenoceptor. Further studies are needed to fully understand the mechanism of ANK-308 and NK -542 and to determine their safety and efficacy as potential drugs for the treatment of anxiety and aggression disorders.

Protein Name: Alpha1-Adrenoceptor (nonspecified Subtype)

The "alpha1-Adrenoceptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about alpha1-Adrenoceptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets